Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,620 | -944 | -3,882 | -2,521 | -5,906 |
| Depreciation Amortization | 73 | 44 | 226 | 137 | 107 |
| Accounts receivable | N/A | N/A | N/A | -9 | N/A |
| Other Working Capital | -242 | 237 | -4,256 | -4,291 | -1,312 |
| Other Operating Activity | -4,329 | 6,096 | 16,357 | 11,102 | 8,350 |
| Operating Cash Flow | $-6,118 | $5,433 | $8,445 | $4,418 | $1,239 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -49 | -49 | N/A |
| Other Investing Activity | 985 | 0 | -1,261 | -232 | -211 |
| Investing Cash Flow | $985 | $N/A | $-1,310 | $-281 | $-211 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 27 | 31 | 31 |
| Common Stock Repurchased | -49 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $-49 | $N/A | $27 | $31 | $31 |
| Beginning Cash Position | 8,683 | 8,683 | 1,521 | 1,521 | 1,521 |
| End Cash Position | 3,501 | 14,116 | 8,683 | 5,689 | 2,580 |
| Net Cash Flow | $-5,182 | $5,433 | $7,162 | $4,168 | $1,059 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,118 | 5,433 | 8,445 | 4,418 | 1,239 |
| Capital Expenditure | N/A | N/A | -49 | -49 | N/A |
| Free Cash Flow | -6,118 | 5,433 | 8,396 | 4,369 | 1,239 |